VISIOPHARM A/S
CVR: 26186676
The financial health of VISIOPHARM A/S shows significant challenges, with consistent losses over the past five years. Revenue has fluctuated slightly, peaking at 135,974,000 DKK in 2022 but declining to 130,617,000 DKK in 2025, while profit margins remain negative, culminating in a loss of 17,223,000 DKK in 2025. Equity has deteriorated sharply from 59,406,000 DKK in 2021 to -4,949,000 DKK in 2025, indicating a concerning trend of increasing financial instability. The company's position within the computer consulting and facility management industry appears precarious, with ongoing profitability issues and a declining equity base raising concerns about its sustainability and growth potential.
AI-generated summary
Overview
- Company type
- A/S
- Aktieselskab
- Founded
- 9.7.2001
Details
- Employees
- 48 employees
- 34 FTE
- (2018)
- Capital
- 1.704.214 kr.
Contact
- Phone
- Log in to see
Purpose
Selskabets formål er at drive virksomhed med udvikling og salg af produkter og serviceydelser til brug indenfor drug discovery og anden i forbindelse dermed stående virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 130.6 mio. | -17.2 mio. | 97.9 mio. | -4.9 mio. | 82 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area